Atrium Therapeutics annual revenue
2023
2024
2025
Atrium Therapeutics Revenue Growth & History (RNA)
Atrium Therapeutics reported $18.6M in revenue for fiscal 2025, an increase of 70.85% from the previous fiscal year.
View full Atrium Therapeutics company overviewAtrium Therapeutics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $18.6M | $7.7M | +70.85% |
| 2024 | 2024-12-31 | $10.9M | $1.1M | +11.60% |
| 2023 | 2023-12-31 | $9.8M | — | — |
Atrium Therapeutics quarterly revenue
Q4.24
Q1.26
Q2.26
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 · Jun 30 | 2026-06-30 | $3.0M | −$843,000 | −21.91% |
| Q1 2026 · Mar 31 | 2026-03-31 | $19.6M | $18.1M | +1148.25% |
| Q4 2025 | 2025-12-31 | $859,000 | −$2.1M | −71.11% |
| Q3 2025 | 2025-09-30 | $12.3M | — | — |
| Q2 2026 · Jun 30 | 2025-06-30 | $3.8M | — | — |
| Q1 2026 · Mar 31 | 2025-03-31 | $1.6M | — | — |
| Q4 2024 | 2024-12-31 | $3.0M | — | — |
Atrium Therapeutics revenue growth trends
Atrium Therapeutics's latest reported quarter, Q2 2026 · Jun 30, generated $3.0M in revenue, a decrease of 21.91% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Atrium Therapeutics source filings ↗